Thursday, October 27, 2016: 10:30 AM-11:00 AM
Room: 391-392
Learning Objectives:
.
Tracks: Pediatric ID, Investigative ID
Moderator:
Janet Gilsdorf, MD, FIDSA, FPIDS, University of Michigan Medical Center
Presentations:
10:30 AM
Impact of the Revised Guidelines for Respiratory Syncytial Virus (RSV) Prophylaxis: Morbidity Persists AfterTwo Seasons!
Phillip Wozniak, BA
;
Pablo J. Sanchez, MD, FIDSA, FPIDS
;
Bavani Rajah, BS
;
Patricia Gruber, RN
;
Jacqueline Magers, PharmD
;
Octavio Ramilo, MD, FPIDS
;
Asuncion Mejias, MD, PhD
10:45 AM
Safety, Tolerability and Pharmacokinetics (PK) of Intravenous Zanamivir (IVZ) Treatment in Hospitalized Pediatric and Adolescent Patients with Influenza: A Phase II Open-Label, Multicenter, Single- Arm Study
Jeffrey Blumer, MD, PhD
;
John S. Bradley, MD, FIDSA, FPIDS
;
Jose R. Romero, MD
;
Marian Michaels, MD, MPH
;
David W. Kimberlin, MD, FIDSA, FPIDS
;
Go Yamamoto, MD
;
Grace Roberts, MS
;
Mohammad Hossain, PhD
;
Denise Shortino, MS
;
Phillip Yates, PhD
;
Bryan Adams, PhD
;
Amanda Peppercorn, MD
CME Credits: No CME credit is offered for this session.
ACPE Credits:
ACPE Number:
